Azitra brings in Series A to advance microbiome skin therapies
The Connecticut company is developing microbiome therapeutics to treat skin conditions like eczema, rashes caused by cancer treatment and Netherton, a chronic, orphan disease.
The expanding ecosystem of microbiome startups
More funding and another powerful pharma backer have entered the microbiome space, showing that at least some investors and pharma execs believe the field can begin converting preclinical ideas into valid human therapies.
Balancing the Role of Physicians and AI [Video]
At the ViVE conference in LA, Smarter Technologies Chief Medical Officer Ruben Amarasingham MD talked with Katie Adams about the company's larger goals for AI: to improve the accuracy of data and make healthcare less burdensome for physicians and clinicians.